SYLVIA CUNNINGHAM: Open Payments
NPI 1881669430 · HIRAM, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 28 payments from 10 companies in 2025. Trend: 2023 $176 · 2024 $452 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $128 |
| Abbott Laboratories | 5 | $85 |
| PFIZER INC. | 4 | $83 |
| ABBVIE INC. | 4 | $75 |
| Dexcom, Inc. | 2 | $61 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Lilly USA, LLC | 2 | $29 |
| Saluda Medical Americas, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
Products named: FREESTYLE LIBRE 3, Dexcom G6 Transmitter, ELIQUIS, Rybelsus, UBRELVY, SHINGRIX, Wegovy, Ozempic.
Industry payments across GA — which companies pay providers there.
